Combination and sequential therapy for osteoporosis.
作者信息
Heaney Robert P, Recker Robert R
出版信息
N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.
PMID:16093472
Abstract
摘要
相似文献
1
Combination and sequential therapy for osteoporosis.
N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.
2
Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92.
3
[Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Clin Calcium. 2007 Dec;17(12):1888-94.
4
Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92.
5
Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
J Bone Miner Res. 1997 Aug;12(8):1152-4. doi: 10.1359/jbmr.1997.12.8.1152.
6
Daily and cyclic parathyroid hormone in women receiving alendronate.
N Engl J Med. 2005 Aug 11;353(6):566-75. doi: 10.1056/NEJMoa050157.
7
Parathyroid hormone plus alendronate--a combination that does not add up.
N Engl J Med. 2003 Sep 25;349(13):1277-9. doi: 10.1056/NEJMe038143. Epub 2003 Sep 20.
8
Sequential parathyroid hormone/alendronate therapy for osteoporosis--robbing Peter to pay Paul?
J Clin Endocrinol Metab. 2000 Jun;85(6):2127-8. doi: 10.1210/jcem.85.6.6658.
9
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
N Engl J Med. 2005 Aug 11;353(6):555-65. doi: 10.1056/NEJMoa050336.
10
Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year.
Scand J Gastroenterol. 2005 Jul;40(7):873-4. doi: 10.1080/00365520510023279.
引用本文的文献
1
Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China.
Front Public Health. 2022 Feb 24;10:794861. doi: 10.3389/fpubh.2022.794861. eCollection 2022.
2
Profile of teriparatide in the management of postmenopausal osteoporosis.
Int J Womens Health. 2010 Aug 9;2:37-44. doi: 10.2147/ijwh.s4919.
3
The use of parathyroid hormone in the treatment of osteoporosis.
Rev Endocr Metab Disord. 2006 Jun;7(1-2):113-21. doi: 10.1007/s11154-006-9007-z.
4
Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
Curr Osteoporos Rep. 2006 Mar;4(1):5-13. doi: 10.1007/s11914-006-0009-2.
Zotero 插件